Novozymes A/S (CPH:NSIS.B)
Denmark · Delayed Price · Currency is DKK 387.70
+4.40 (1.15%)
May 22, 2026, 4:59 PM CET
Novozymes Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,199 | 4,158 | 3,834 | 2,402 | 2,355 | 2,011 | |
Revenue Growth (YoY) | 3.49% | 8.45% | 59.58% | 1.99% | 17.14% | 6.46% |
Cost of Revenue | 1,917 | 1,916 | 2,024 | 1,097 | 1,070 | 851.01 |
Gross Profit | 2,282 | 2,242 | 1,810 | 1,305 | 1,285 | 1,160 |
Selling, General & Admin | 944.4 | 911.8 | 765.5 | 446.1 | 432.47 | 375.88 |
Research & Development | 477.4 | 463.8 | 413.2 | 270.7 | 268.5 | 270.18 |
Other Operating Expenses | 42.1 | 49.2 | 129.8 | 54.4 | -27.91 | -25.28 |
Total Operating Expenses | 1,464 | 1,425 | 1,309 | 771.2 | 673.05 | 620.77 |
Operating Income | 818 | 816.7 | 501 | 533.6 | 612 | 538.87 |
Interest Income | -6.3 | 28.9 | 23.4 | 35.4 | -0.94 | -0.54 |
Interest Expense | - | -102.2 | -107.3 | -44.3 | - | - |
Other Non-Operating Income (Expense) | -39.3 | - | - | - | 0.27 | -10.62 |
Total Non-Operating Income (Expense) | -45.6 | -73.3 | -83.9 | -8.9 | -0.67 | -11.16 |
Pretax Income | 755.6 | 743.4 | 417.1 | 524.7 | 611.33 | 527.71 |
Provision for Income Taxes | 158.9 | 159.8 | 111.3 | 116.8 | 116.74 | 104.76 |
Net Income | 596.7 | 583.6 | 305.8 | 405.9 | 493.25 | 423.08 |
Minority Interest in Earnings | - | - | - | 2 | 1.34 | -0.13 |
Net Income to Common | 596.7 | 583.6 | 305.8 | 405.9 | 493.25 | 423.08 |
Net Income Growth | 30.14% | 90.84% | -24.66% | -17.71% | 16.58% | 11.11% |
Shares Outstanding (Basic) | 466 | 466 | 458 | 277 | 277 | 278 |
Shares Outstanding (Diluted) | 466 | 468 | 460 | 278 | 279 | 280 |
Shares Change (YoY) | 10.86% | 1.73% | 65.40% | -0.31% | -0.52% | -0.65% |
EPS (Basic) | 1.28 | 1.25 | 0.67 | 1.47 | 1.78 | 1.52 |
EPS (Diluted) | 1.28 | 1.25 | 0.67 | 1.46 | 1.77 | 1.51 |
EPS Growth | 29.29% | 86.57% | -54.11% | -17.51% | 17.22% | 11.85% |
Shares Outstanding | 279.93 | 465.91 | 279.84 | 277.32 | 276.6 | 277.11 |
Free Cash Flow | 838.7 | 811.7 | 681.6 | 308 | 167.19 | 402.24 |
Free Cash Flow Growth | 3.33% | 19.09% | 121.30% | 84.22% | -58.44% | -16.20% |
Free Cash Flow Per Share | 1.80 | 1.74 | 1.48 | 1.11 | 0.60 | 1.44 |
Dividends Per Share | 0.870 | 0.870 | 0.830 | - | 0.807 | 0.740 |
Dividend Growth | - | 4.86% | - | - | 9.05% | 4.88% |
Gross Margin | 54.34% | 53.91% | 47.20% | 54.32% | 54.56% | 57.68% |
Operating Margin | 19.48% | 19.64% | 13.07% | 22.21% | 25.98% | 26.80% |
Profit Margin | 14.21% | 14.04% | 7.98% | 16.98% | 21.00% | 21.04% |
FCF Margin | 19.97% | 19.52% | 17.78% | 12.82% | 7.10% | 20.01% |
EBITDA | 818 | 1,414 | 1,098 | 720 | 612 | 538.87 |
EBITDA Margin | 19.48% | 34.00% | 28.65% | 29.97% | 25.98% | 26.80% |
EBIT | 818 | 816.7 | 501 | 533.6 | 612 | 538.87 |
EBIT Margin | 19.48% | 19.64% | 13.07% | 22.21% | 25.98% | 26.80% |
Effective Tax Rate | 21.03% | 21.50% | 26.68% | 22.26% | 19.10% | 19.85% |
Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.